Logo image of SRI

STONERIDGE INC (SRI) Stock Fundamental Analysis

NYSE:SRI - New York Stock Exchange, Inc. - US86183P1021 - Common Stock - Currency: USD

3.64  -0.14 (-3.7%)

Fundamental Rating

3

Overall SRI gets a fundamental rating of 3 out of 10. We evaluated SRI against 81 industry peers in the Automobile Components industry. SRI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SRI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SRI has reported negative net income.
In the past year SRI had a positive cash flow from operations.
SRI had negative earnings in 4 of the past 5 years.
Of the past 5 years SRI 4 years had a positive operating cash flow.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SRI has a Return On Assets of -2.66%. This is amonst the worse of the industry: SRI underperforms 81.48% of its industry peers.
SRI's Return On Equity of -6.74% is on the low side compared to the rest of the industry. SRI is outperformed by 81.48% of its industry peers.
SRI has a worse Return On Invested Capital (0.38%) than 82.72% of its industry peers.
SRI had an Average Return On Invested Capital over the past 3 years of 1.22%. This is significantly below the industry average of 8.88%.
Industry RankSector Rank
ROA -2.66%
ROE -6.74%
ROIC 0.38%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)1.22%
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

SRI has a worse Operating Margin (0.25%) than 82.72% of its industry peers.
In the last couple of years the Operating Margin of SRI has declined.
SRI's Gross Margin of 20.90% is on the low side compared to the rest of the industry. SRI is outperformed by 69.14% of its industry peers.
In the last couple of years the Gross Margin of SRI has declined.
Industry RankSector Rank
OM 0.25%
PM (TTM) N/A
GM 20.9%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRI is destroying value.
SRI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SRI has been increased compared to 5 years ago.
SRI has a worse debt/assets ratio than last year.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.51 indicates that SRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
SRI has a Altman-Z score of 2.51. This is comparable to the rest of the industry: SRI outperforms 55.56% of its industry peers.
SRI has a debt to FCF ratio of 8.60. This is a slightly negative value and a sign of low solvency as SRI would need 8.60 years to pay back of all of its debts.
SRI has a worse Debt to FCF ratio (8.60) than 71.60% of its industry peers.
SRI has a Debt/Equity ratio of 0.82. This is a neutral value indicating SRI is somewhat dependend on debt financing.
The Debt to Equity ratio of SRI (0.82) is worse than 82.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.6
Altman-Z 2.51
ROIC/WACC0.04
WACC9.57%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 2.58 indicates that SRI has no problem at all paying its short term obligations.
SRI's Current ratio of 2.58 is amongst the best of the industry. SRI outperforms 80.25% of its industry peers.
A Quick Ratio of 1.57 indicates that SRI should not have too much problems paying its short term obligations.
SRI has a better Quick ratio (1.57) than 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.57
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SRI have decreased strongly by -176.47% in the last year.
Looking at the last year, SRI shows a decrease in Revenue. The Revenue has decreased by -6.92% in the last year.
The Revenue has been growing slightly by 1.71% on average over the past years.
EPS 1Y (TTM)-176.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.64%
Revenue 1Y (TTM)-6.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-4.91%

3.2 Future

SRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.31% yearly.
The Revenue is expected to grow by 2.16% on average over the next years.
EPS Next Y15.76%
EPS Next 2Y65.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.3%
Revenue Next 2Y2.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

SRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SRI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRI.
92.59% of the companies in the same industry are more expensive than SRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.32
EV/EBITDA 6.31
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as SRI's earnings are expected to grow with 65.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.31%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SRI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STONERIDGE INC

NYSE:SRI (4/21/2025, 3:56:04 PM)

3.64

-0.14 (-3.7%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners97.94%
Inst Owner Change0.02%
Ins Owners2.41%
Ins Owner Change5.27%
Market Cap101.37M
Analysts86.67
Price Target14.28 (292.31%)
Short Float %1.69%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-371.29%
Min EPS beat(2)-397.03%
Max EPS beat(2)-345.54%
EPS beat(4)1
Avg EPS beat(4)-61.39%
Min EPS beat(4)-444.55%
Max EPS beat(4)941.58%
EPS beat(8)5
Avg EPS beat(8)34.74%
EPS beat(12)7
Avg EPS beat(12)35.8%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.24%
Min Revenue beat(2)-7.81%
Max Revenue beat(2)-2.68%
Revenue beat(4)1
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)6.19%
Revenue beat(8)3
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)2.97%
Revenue beat(16)10
Avg Revenue beat(16)3.62%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-248%
EPS NY rev (1m)-492%
EPS NY rev (3m)-492%
Revenue NQ rev (1m)-8.06%
Revenue NQ rev (3m)-8.6%
Revenue NY rev (1m)-6.32%
Revenue NY rev (3m)-8.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 4.32
P/OCF 2.12
P/B 0.41
P/tB 0.59
EV/EBITDA 6.31
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)0.84
FCFY23.13%
OCF(TTM)1.71
OCFY47.1%
SpS32.61
BVpS8.81
TBVpS6.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -6.74%
ROCE 0.48%
ROIC 0.38%
ROICexc 0.45%
ROICexgc 0.55%
OM 0.25%
PM (TTM) N/A
GM 20.9%
FCFM 2.58%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)1.22%
ROIC(5y)N/A
ROICexc(3y)1.34%
ROICexc(5y)N/A
ROICexgc(3y)1.64%
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-44.52%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.72%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score6
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.6
Debt/EBITDA 5.41
Cap/Depr 69.45%
Cap/Sales 2.68%
Interest Coverage 0.15
Cash Conversion 128.17%
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 1.57
Altman-Z 2.51
F-Score6
WACC9.57%
ROIC/WACC0.04
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-176.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.64%
EPS Next Y15.76%
EPS Next 2Y65.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-4.91%
Revenue Next Year-5.3%
Revenue Next 2Y2.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.97%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year153.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y169.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y865.39%
OCF growth 3YN/A
OCF growth 5Y14.27%